ENTITY
Yichang HEC Changjiang Pharma

Yichang HEC Changjiang Pharma (1558 HK)

83
Analysis
Health CareHong Kong
YiChang HEC ChangJiang Pharmaceutical Co Ltd develops a variety of drugs. The Company develops and sells drugs for anti-virus, metabolic diseases, cardiovascular, and more.
more
25 Nov 2019 14:40

Hong Kong Buyback Weekly: Yichang HEC, Weimob and China Literature

In the past 7 days, the top 3 companies that repurchased the most shares from the market were Yichang Hec Changjiang Pharm (1558 HK) (HKD 42.3...

Logo
324 Views
Share
bullishMeituan
18 Nov 2019 22:40

HK Connect Flows: Close Meituan/Elong Trade with a 14.5% Profit

In our weekly HK Connect Flow series, we aim to help our investors understand the flow of southbound trades via the Hong Kong Connect, as analyzed...

Logo
341 Views
Share
18 Nov 2019 10:33

Hong Kong Buyback Weekly: Yichang HEC, Viva Biotech, China Literature Led the Buybacks

In the past 7 days, the top 3 companies that repurchased the most shares from the market were Yichang Hec Changjiang Pharmaceutical Co., Ltd. (1558...

Logo
277 Views
Share
bullishMeituan
12 Nov 2019 11:40

HK Connect Flows: USD 729 Million Inflows into Meituan Since Inclusion

In our weekly HK Connect Flow series, we aim to help our investors understand the flow of southbound trades via the Hong Kong Connect, as analyzed...

Logo
401 Views
Share
bullishMeituan
04 Nov 2019 17:20

HK Connect Flows: $248m Inflows into Meituan on the First Day of Inclusion

In our weekly HK Connect Flow series, we aim to help our investors understand the flow of southbound trades via the Hong Kong Connect, as analyzed...

Logo
335 Views
Share
x